Characterizing Stroke Clots Using Single-Cell Sequencing

<h4>Background</h4>Ischemic stroke results in significant morbidity and mortality. By examining gene expression of cells comprising stroke clots, we aim to gain valuable insights into the underlying mechanisms of this disease and identify potential biomarkers of stroke cause.<h4>Methods</h4>We employed single-cell RNA sequencing to analyze 10 clot samples from patients diagnosed with large vessel occlusion stroke. We aimed to identify and compare the immune cell compositions and gene expression profiles between stroke clots (atrial fibrillation vs carotid atherosclerosis). We also used Multi-marker Analysis of Genomic Annotation and genome-wide association studies summary statistics from the GIGASTROKE consortium to assess associations between genetic variants and cell type-specific gene expression within the stroke subtypes.<h4>Results</h4>Our analysis revealed distinct immune cell populations, including monocytes, macrophages, dendritic cells, neutrophils, and T cells in both clot types. Notably, we observed significant differences in gene expression within the mononuclear phagocytic system cells between clots from patients with atrial fibrillation and carotid atherosclerosis. We identified specific genes associated with atherosclerosis and stroke-related processes, such as <i>CD74, HLA-DRB1*01, HTRA1, C1Q, CD81</i>, and <i>CR1</i> from patients with carotid atherosclerosis. In atrial fibrillation clots, CD8 T cells and natural killer cells show upregulated expression of genes such as <i>GZMH</i>, <i>GZMB</i>, <i>S100A4</i>, <i>FCGBP2</i>, <i>HLA-A</i>, <i>TIMP1</i>, <i>CLIC1</i>, and <i>IFITM2</i>, indicating their involvement in cytotoxic activities and potential tissue damage. The Multi-marker Analysis of Genomic Annotation approach highlighted significant genetic associations within leukocytes underscoring the potential roles of B cells, T cells, and macrophages in clot pathogenesis.<h4>Conclusions</h4>This study illuminates the immune and transcriptomic landscape within clots, offering potential biomarkers and lays the foundation for future research.